Synthetic compounds that mimic traditional drugs but skirt legal frameworks are complicating addiction landscapes. The proliferation of novel psychoactive substances and emerging drug trends poses significant risks due to unpredictable potency and side effects. These substances often evade detection by standard drug screens, challenging clinicians during diagnosis and treatment. From synthetic cannabinoids to designer stimulants, their impact can be severe, leading to hospitalizations, psychosis, or fatal overdoses. Monitoring systems and toxicological advancements are now essential in keeping pace with new variants. Public awareness campaigns, rapid policy adaptation, and global data sharing are crucial to curbing the spread and harm of these unpredictable substances.
Title : The root causes of addiction and mental health that are not being addressed: Where science meets recovery
John J Giordano, Life Enhancement Recovery Center, United States
Title : Consent: Yes means yes - unless it means no
Sam Vaknin, Commonwealth Institute of Advanced Professional Studies (CIAPS), United Kingdom
Title : Profiling kidney donors
Meni Koslowsky, Ariel University, Israel
Title : Beyond the diagnosis: Unlocking the adolescent brain – school neuropsychological case studies in addiction, mental health, learning, and evidence-based interventions
Ann Marie Leonard Zabel, Curry College and NEALAC Clinic , United States